• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉血管成形术后的再狭窄能否根据临床变量预测?

Can restenosis after coronary angioplasty be predicted from clinical variables?

作者信息

Weintraub W S, Kosinski A S, Brown C L, King S B

机构信息

Andreas Gruentzig Cardiovascular Center, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.

出版信息

J Am Coll Cardiol. 1993 Jan;21(1):6-14. doi: 10.1016/0735-1097(93)90711-9.

DOI:10.1016/0735-1097(93)90711-9
PMID:8417077
Abstract

OBJECTIVES

The purpose of this study was to determine whether variables shown to correlate with restenosis in one group (learning group) could be shown to predict recurrent stenosis in a second group (validation group).

BACKGROUND

Restenosis remains a critical limitation after percutaneous transluminal coronary angioplasty. Although several clinical variables have been shown to correlate with restenosis, there are few data concerning attempts to predict recurrent stenosis.

METHODS

The source of data was the clinical data base at Emory University. Patients who had had previous coronary surgery and patients who underwent coronary angioplasty in the setting of acute myocardial infarction were excluded. A total of 4,006 patients with angiographic restudy after successful angioplasty were identified. They were classified into a learning group of 2,500 patients and a validation group of 1,506 patients. The correlates of restenosis in the learning group were determined by stepwise logistic regression, and a model was developed to predict the probability of restenosis and was tested in the validation group. By using various cut points for the predicted probability of restenosis, a receiver operating characteristic curve was created. Goodness of fit of the model was evaluated by comparing average predicted probabilities with average observed probabilities within subgroups on the basis of risk level determined by linear regression analysis.

RESULTS

In the learning group 1,145 patients had restenosis and 1,355 did not. Correlates of restenosis were severe angina, severe diameter stenosis before angioplasty, left anterior descending coronary artery dilation, diabetes, greater diameter stenosis after angioplasty, hypertension, absence of an intimal tear, eccentric morphology and older patient age. The model derived from the learning group was used to predict restenosis in the validation group. By varying the cut point for the predicted probability of restenosis above which restenosis is diagnosed and below which it is not, a receiver operating characteristic curve was created. The curve was close to the line of identity, reflecting a poor predictive ability. However, the model was shown to fit well with the predicted probability of restenosis correlating well with the observed probability (r = 0.98, p = 0.0001).

CONCLUSIONS

Clinical variables provide limited ability to predict definitively whether a particular patient will have restenosis. However, the current model may be used to predict the probability of restenosis, with some uncertainty, at least in well characterized patients who have already had angioplasty.

摘要

目的

本研究旨在确定在一组患者(学习组)中显示与再狭窄相关的变量是否能预测另一组患者(验证组)的复发性狭窄。

背景

经皮腔内冠状动脉成形术后,再狭窄仍然是一个关键的限制因素。虽然已经显示一些临床变量与再狭窄相关,但关于预测复发性狭窄的尝试的数据很少。

方法

数据来源是埃默里大学的临床数据库。排除曾接受过冠状动脉手术的患者以及在急性心肌梗死情况下接受冠状动脉成形术的患者。共确定了4006例成功进行血管成形术后接受血管造影复查的患者。他们被分为一个由2500例患者组成的学习组和一个由1506例患者组成的验证组。通过逐步逻辑回归确定学习组中再狭窄的相关因素,并建立一个模型来预测再狭窄的概率,并在验证组中进行测试。通过使用再狭窄预测概率的各种切点,创建了一个受试者操作特征曲线。通过将基于线性回归分析确定的风险水平的亚组内平均预测概率与平均观察概率进行比较,评估模型的拟合优度。

结果

在学习组中,1145例患者发生再狭窄,1355例未发生。再狭窄的相关因素包括严重心绞痛、血管成形术前严重直径狭窄、左前降支冠状动脉扩张、糖尿病、血管成形术后更大直径狭窄、高血压、无内膜撕裂、偏心形态和患者年龄较大。从学习组得出的模型用于预测验证组中的再狭窄。通过改变再狭窄预测概率的切点(高于该切点诊断为再狭窄,低于该切点则不是),创建了一个受试者操作特征曲线。该曲线接近恒等线,反映出预测能力较差。然而,该模型显示与再狭窄预测概率与观察概率相关性良好(r = 0.98,p = 0.0001)。

结论

临床变量在明确预测特定患者是否会发生再狭窄方面能力有限。然而,当前模型可用于预测再狭窄的概率,至少在已经接受血管成形术的特征明确的患者中存在一定不确定性。

相似文献

1
Can restenosis after coronary angioplasty be predicted from clinical variables?冠状动脉血管成形术后的再狭窄能否根据临床变量预测?
J Am Coll Cardiol. 1993 Jan;21(1):6-14. doi: 10.1016/0735-1097(93)90711-9.
2
Long-term clinical follow-up in patients with angiographic restudy after successful angioplasty.血管成形术成功后接受血管造影复查患者的长期临床随访
Circulation. 1993 Mar;87(3):831-40. doi: 10.1161/01.cir.87.3.831.
3
Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART Investigators.冠状动脉血管成形术后再狭窄:一种将病变和操作变量与再狭窄相关联的多变量统计模型。M-HEART研究组。
J Am Coll Cardiol. 1991 Sep;18(3):647-56. doi: 10.1016/0735-1097(91)90783-6.
4
Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy.
J Am Coll Cardiol. 1993 Jan;21(1):15-25. doi: 10.1016/0735-1097(93)90712-a.
5
Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty.普伐他汀对冠状动脉球囊血管成形术后血管造影再狭窄的影响。PREDICT试验研究者。腔内冠状动脉血管成形术后依立索预防再狭窄。
J Am Coll Cardiol. 1997 Oct;30(4):863-9. doi: 10.1016/s0735-1097(97)00259-3.
6
Detection of restenosis after successful coronary angioplasty: improved clinical decision making with use of a logistic model combining procedural and follow-up variables.
J Am Coll Cardiol. 1990 Nov;16(6):1333-40. doi: 10.1016/0735-1097(90)90373-w.
7
Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.快速进展性冠状动脉狭窄冠状动脉成形术后再狭窄
Eur Heart J. 1996 Nov;17(11):1671-7. doi: 10.1093/oxfordjournals.eurheartj.a014750.
8
Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.患者、病变及手术相关变量作为成功冠状动脉血管成形术后管腔再狭窄的危险因素:对653例患者778处病变的定量分析。血管成形术后应用西拉普利预防经腔冠状动脉阻塞和再狭窄的多中心欧洲研究试验(MERCATOR)研究组。
J Cardiovasc Pharmacol. 1993;22 Suppl 4:S45-57.
9
Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
Am Heart J. 1994 Mar;127(3):483-94. doi: 10.1016/0002-8703(94)90654-8.
10
Restenosis rate after multiple percutaneous transluminal coronary angioplasty procedures at the same site. A quantitative angiographic study in consecutive patients undergoing a third angioplasty procedure for a second restenosis.同一部位多次经皮腔内冠状动脉成形术后的再狭窄率。一项对因第二次再狭窄接受第三次血管成形术的连续患者进行的定量血管造影研究。
Circulation. 1993 Sep;88(3):969-74. doi: 10.1161/01.cir.88.3.969.

引用本文的文献

1
A systematic review of clinical and biomechanical engineering perspectives on the prediction of restenosis in coronary and peripheral arteries.冠状动脉和外周动脉再狭窄预测的临床与生物力学工程视角的系统综述。
JVS Vasc Sci. 2023 Sep 15;4:100128. doi: 10.1016/j.jvssci.2023.100128. eCollection 2023.
2
Genetic Variants in PHACTR1 & LPL Mediate Restenosis Risk in Coronary Artery Patients.PHACTR1 和 LPL 基因变异与冠状动脉患者再狭窄风险相关。
Vasc Health Risk Manag. 2023 Feb 16;19:83-92. doi: 10.2147/VHRM.S394695. eCollection 2023.
3
Long-term follow-up of coronary angioplasty in patients with diabetes compared with nondiabetics.
糖尿病患者与非糖尿病患者冠状动脉血管成形术的长期随访
Neth Heart J. 2004 Apr;12(4):144-150.
4
Influence of the angiotensin converting enzyme insertion or deletion genetic variant and coronary restenosis risk: evidence based on 11,193 subjects.血管紧张素转换酶插入或缺失基因变异与冠状动脉再狭窄风险的关系:基于11193名受试者的证据
PLoS One. 2013 Dec 13;8(12):e83415. doi: 10.1371/journal.pone.0083415. eCollection 2013.
5
Genetic polymorphism of angiotensin converting enzyme and risk of coronary restenosis after percutaneous transluminal coronary angioplasties: evidence from 33 cohort studies.血管紧张素转换酶基因多态性与经皮腔内冠状动脉成形术后冠状动脉再狭窄的风险:来自 33 项队列研究的证据。
PLoS One. 2013 Sep 30;8(9):e75285. doi: 10.1371/journal.pone.0075285. eCollection 2013.
6
Association between C1019T polymorphism of the connexin37 gene and coronary heart disease in patients with in-stent restenosis.连接蛋白37基因C1019T多态性与支架内再狭窄患者冠心病的关系。
Exp Ther Med. 2013 Feb;5(2):539-544. doi: 10.3892/etm.2012.852. Epub 2012 Dec 5.
7
Coronary aspirate TNFα reflects saphenous vein bypass graft restenosis risk in diabetic patients.冠状动脉抽吸 TNFα 反映糖尿病患者隐静脉旁路移植再狭窄的风险。
Cardiovasc Diabetol. 2013 Jan 10;12:12. doi: 10.1186/1475-2840-12-12.
8
Choosing a revascularization strategy in patients with diabetes and stable coronary artery disease: a complex decision.为糖尿病合并稳定型冠状动脉疾病患者选择血运重建策略:一项复杂的决策。
Curr Cardiol Rev. 2010 Nov;6(4):333-6. doi: 10.2174/157340310793566064.
9
Restenosis after PCI. Part 1: pathophysiology and risk factors.经皮冠状动脉介入治疗(PCI)后的再狭窄。第 1 部分:病理生理学和危险因素。
Nat Rev Cardiol. 2011 Sep 13;9(1):53-62. doi: 10.1038/nrcardio.2011.132.
10
Novel QCA methodologies and angiographic scores.新型 QCA 方法学和血管造影评分。
Int J Cardiovasc Imaging. 2011 Feb;27(2):157-65. doi: 10.1007/s10554-010-9787-9. Epub 2011 Feb 20.